Particle Counting and Identification

Particle Counting and Identification

Subvisible particles can cause a range of serious health issues, with effects that can be alarming. Aura Systems make it possible to detect and characterize subvisible particles early in development using as little as 5 µL per test, delivering results in about one minute per sample while maintaining USP 788 compliance and helping protect patient safety.

Subvisible particles can cause a range of serious health issues, with effects that can be alarming. Aura Systems make it possible to detect and characterize subvisible particles early in development using as little as 5 µL per test, delivering results in about one minute per sample while maintaining USP 788 compliance and helping protect patient safety.

Plexus intermeshed into form wave
Plexus intermeshed into form wave

Overview

Subvisible particles, measuring roughly 10 µm in size, can cause a range of serious health issues, from clogging capillaries to sparking life-threatening immune reactions. In response, the FDA has set strict standards for injectable drug products: they must be virtually free of them. Manufacturers need powerful technology solutions capable of fully characterizing subvisible particles throughout the development cycle to ensure therapies are safe and effective prior to patient use. Yet legacy particle analysis methods fail to provide adequate protection, leaving invisible particles unchecked and patient safety in danger.

With Aura Systems, subvisible particle counting and identification is possible at the very beginning of your process, a big step forward in speeding up development and helping prevent expensive bottlenecks. Discover how the Aura family of particle analyzers can help you develop stable, pure and efficacious protein, cell, and gene therapies faster, while preventing problems before they become expensive bottlenecks:

  • Screen a wide range of conditions using a 96-well format with high reproducibility and only 5 µL per test for better, clearer decisions
  • Screen particulate contamination in pharmaceuticals and bacterial contamination in cell culture media
  • Evaluate particle sizes from 1 µm to 5 mm and obtain USP 788-compliant data in about one minute per sample
  • Achieve high sensitivity as particles are imaged without the interference of buffer or matrix
  • Avoid wasting time or money on products that won’t make it through development
  • See more detail for better particle identification with high-resolution magnification
  • Maintain compliance with the option for 21 CFR Part 11 software

Applications

Subvisible particle counting is of the utmost importance, as it allows you to accurately characterize large visible contaminants and ensure patient safety. The Aura Platform provides a USP 788 compendial method that is rapid and robust. Unlike other subvisible particle analysis methods, Aura Systems can handle a broad range of sample types and volumes, enabling continuity of method from candidate selection to lot release. Aggregates that form due to degraded polysorbate in your formulation can be quickly identified and counted. When you can assess visible and subvisible particles using microliter volumes at high throughput, you gain a powerful screening tool that speeds up development from pre-IND into clinical phases.

Subvisible particle counting is of the utmost importance, as it allows you to accurately characterize large visible contaminants and ensure patient safety. The Aura Platform provides a USP 788 compendial method that is rapid and robust. Unlike other subvisible particle analysis methods, Aura Systems can handle a broad range of sample types and volumes, enabling continuity of method from candidate selection to lot release. Aggregates that form due to degraded polysorbate in your formulation can be quickly identified and counted. When you can assess visible and subvisible particles using microliter volumes at high throughput, you gain a powerful screening tool that speeds up development from pre-IND into clinical phases.


Meet the people behind the quality products you use from Waters as they discuss the analytical challenges and opportunities facing scientists involved in established and trending applications

Using backgrounded membrane imaging (BMI) and fluorescence membrane microscopy (FMM), Aura Systems uncover crucial subvisible particle data, including size, particle diameter, morphology, count, and distribution, which leads to more accurate results and better insight. Detect and characterize particles not measured by dynamic light scattering (DLS) or size exclusion chromatography (SEC) while preserving your sample.

You achieve high sensitivity because particles are imaged and identified through fluorescence methods without the interference of buffer or matrix and see more detail for better particle identification with high-resolution magnification.

Using backgrounded membrane imaging (BMI) and fluorescence membrane microscopy (FMM), Aura Systems uncover crucial subvisible particle data, including size, particle diameter, morphology, count, and distribution, which leads to more accurate results and better insight. Detect and characterize particles not measured by dynamic light scattering (DLS) or size exclusion chromatography (SEC) while preserving your sample.

You achieve high sensitivity because particles are imaged and identified through fluorescence methods without the interference of buffer or matrix and see more detail for better particle identification with high-resolution magnification.



Stay current on the latest instrument intelligence in UPLC and HPLC and how it is reshaping analytical productivity with our podcast


Application Note: Rapidly Distinguish Protein from Non-Protein Particles in Biologic Formulations

In this application note, we introduce fluorescence membrane microscopy (FMM) exclusively available on the Aura System. FMM is a high throughput, low volume, subvisible particle identification technology that enables ultra-fast, 100% sampling efficiency, characterizing all particles from a single protein aggregate to tens of millions of particles in an entire multi-sample formulation, in under two hours.

In this application note, we introduce fluorescence membrane microscopy (FMM) exclusively available on the Aura System. FMM is a high throughput, low volume, subvisible particle identification technology that enables ultra-fast, 100% sampling efficiency, characterizing all particles from a single protein aggregate to tens of millions of particles in an entire multi-sample formulation, in under two hours.


Ion waves particles through the sphere

Solutions


With Aura Systems, obtain information on particle presence and formation early in discovery and development for critical particle analysis insights into developability, stability, formulation, manufacturability and more.

With Aura Systems, obtain information on particle presence and formation early in discovery and development for critical particle analysis insights into developability, stability, formulation, manufacturability and more.

Particle characterization for biotherapeutics

Particle characterization for biotherapeutics

With the ability to support the full range of development and manufacturing applications across therapeutic approaches—including protein/antibody therapeutics, gene therapies, cell therapies, and small molecules— Aura+ System packs powerful flexibility into a single particle analyzer.

  • Particle Counting
  • Particle Identification

Small volume AAV characterization

Small volume AAV characterization

Optimized for gene therapy applications, Aura GT System maximizes what you can learn about your particles while minimizing the amount of sample you need to analyze.

  • Particle Counting
  • Particle Identification

Smart protein analysis and formulation

Smart protein analysis and formulation

Get the most out of your protein therapy quality measurements with Aura PTx System. Our advanced technology can quickly detect, count, and characterize excipients and subvisible particles, giving you valuable insights into drug stability during early stages of product development.

  • Particle Counting
  • Particle Identification

Smarter fluorescence cell imaging

Smarter fluorescence cell imaging

Powered by innovative technology, Aura CL System is the ultimate tool to identify, count, and characterize subvisible particle contaminants introduced in cell therapy manufacturing. Get high-throughput insights earlier in discovery to develop cell therapies faster, smarter, and safer.

  • Particle Counting
  • Particle Identification

Unlock crucial insights at earlier stages of drug development with automated particle analysis software to make your research simpler, faster, and more efficient.

Unlock crucial insights at earlier stages of drug development with automated particle analysis software to make your research simpler, faster, and more efficient.

Get data-driven insights earlier

Get data-driven insights earlier

Simplify discovery with Particle Vue Software, providing automated tools to detect and analyze particles present in a variety of samples. With its advanced algorithms, particle size analysis features, and multi-channel image navigation, the user-friendly experience is tailored for speed and accuracy with minimal effort required.

  • Particle Counting
  • Particle Identification

Achieve testing efficiencies and accurate results using streamlined Waters services and support.

Achieve testing efficiencies and accurate results using streamlined Waters services and support.

Your success is just a click away

Your success is just a click away

Optimize your laboratory's productivity and success with Waters Global Services. Maintain peak system performance, minimize down time, address application challenges, and support stringent compliance requirements.

  • Particle Counting
  • Particle Identification

Make science more accessible

Make science more accessible

Maximize resources and minimize risk with payment options from Waters Capital, including upgrading aging equipment, getting customized support, and bundling services into one monthly payment.

  • Particle Counting
  • Particle Identification

The data speaks for itself

The data speaks for itself

Refractive index differences between protein aggregates in aqueous solutions (FI) and air (HORIZON®). The higher refractive index contrast with the HORIZON® system improves data accuracy, robustness, and sensitivity.

Sizing with the Aura system. (A) Calibration with ASTM Microscope Slide. Particle size verification with (B) 15 µm and (C) 5 µm polystyrene bead standards as shown in the captured images from the Aura Particle Vue software tooltip.

LOQ determination for the Dynabead detection assay. Dynabead counts were measured in serial dilutions of cells mixed with Dynabeads and graphed as the average number of beads/mL vs. dilution. Limit of quantification (LOQ ) shown below dotted line. R2= 0.98.

Subvisible particle counts (>2 µm/mL) for Sample A and Sample B treated with varying buffers.


Webinars and Resources

  • Specification

Aura+ Specification Sheet

Aura+ Specification Sheet
  • Specification

Aura GT Specification Sheet

Aura GT Specification Sheet
  • Specification

Aura CL Specification Sheet

Aura CL Specification Sheet
  • Specification

Aura PTx Specification Sheet

Aura PTx Specification Sheet

Frequently Asked Questions

Frequently Asked Questions

What is the difference between ultrafine particles and nanoparticles?

What is the difference between ultrafine particles and nanoparticles?

Ultrafine particles and nanoparticles are both types of particles with dimensions on the nanometer scale, but they differ in their sources, properties, and applications. Ultrafine particles refer to particles with sizes typically ranging from 1 to 100 nanometers, generated from natural or anthropogenic sources such as combustion processes, industrial emissions, or atmospheric aerosols. Nanoparticles, on the other hand, encompass a broader range of particle sizes up to 1000 nanometers and can be engineered or synthesized for various applications, including drug delivery, imaging, diagnostics, and materials science. While both ultrafine particles and nanoparticles exhibit unique physicochemical properties due to their small size, nanoparticles are designed and manipulated to achieve specific functionalities or behaviors, whereas ultrafine particles may arise as byproducts of natural or human activities.

How do you measure subvisible particles?

How do you measure subvisible particles?

Subvisible particles, which include particles larger than 1 micron in size, can be measured using various analytical techniques to assess the quality and safety of pharmaceutical products. Common methods for measuring subvisible particles include:

  1. Light obscuration (LO): LO methods use a light source and photodetector to measure the decrease in light intensity caused by particles passing through a small detection zone, allowing quantification of particle concentration and size distribution in liquid formulations.
  2. Microscopy particle counting: Microscopic techniques such as optical microscopy or phase-contrast microscopy visually inspect liquid samples under a microscope to manually count and size particles, providing qualitative and quantitative data on particle characteristics. Aura Systems are automated optical microscopy platforms designed specifically for the analysis and measurement of subvisible particles.
  3. Flow imaging microscopy (FIM): FIM systems capture images of particles in liquid samples flowing through a microfluidic channel, allowing automated counting, sizing, and characterization of particles based on their morphology, size, and optical properties.
  4. Laser diffraction: Laser diffraction methods analyze the scattering patterns of laser light passing through a liquid sample containing particles, providing information on particle size distribution and concentration.
  5. Fluorescence Membrane Microscopy (FMM): A key component of the Aura+ and Aura PTx systems, FMM uses specific fluorescent dyes or conjugated antibodies to detect and quantitate subvisible particles.

These methods enable the detection, quantification, and characterization of subvisible particles in pharmaceutical formulations, ensuring compliance with regulatory standards and product specifications.

What are the methods for determining particle size?

What are the methods for determining particle size?

Particle size determination involves measuring the dimensions of particles in a sample, which can vary from nanometers to micrometers depending on the application and analytical technique. Common methods of determining particle size include:

  1. Laser diffraction: Laser diffraction techniques analyze the scattering patterns of laser light passing through a sample containing particles, providing information on particle size distribution based on the diffraction pattern.
  2. Dynamic light scattering (DLS): DLS measures the fluctuations in scattered light intensity caused by the Brownian motion of particles in a suspension, yielding particle size distribution information based on the intensity autocorrelation function.
  3. Nanoparticle tracking analysis (NTA): NTA systems visualize and track individual nanoparticles in suspension using light microscopy and particle tracking algorithms, providing real-time size distribution and concentration data.
  4. Electron microscopy: Electron microscopy techniques such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM) provide high-resolution images of individual particles, allowing direct visualization and measurement of particle size and morphology.
  5. Coulter counter: Coulter counters use the principle of electrical impedance to detect and count particles as they pass through a small aperture, providing information on particle size distribution based on the changes in electrical resistance.
  6. Sieving: Sieving methods involve passing a sample through a series of sieves with progressively smaller mesh sizes, separating particles based on size and providing information on particle size distribution by weight or volume.
  7. Light Microscopy: this traditional technique can directly count and characterize subvisible particles in the size range of 0.8–150 µm, as described in both USP 788 and Ph.Eur.2.9.19. Still, manual light microscopy is low-throughput and produces less accurate results than the light obscuration technique. Aura systems are automated optical microscopy platforms.

These methods offer complementary approaches to characterizing particle size, allowing researchers to select the most suitable technique based on sample properties, size range, and measurement requirements.

What are the quantitative methods for determining particle size distribution?

What are the quantitative methods for determining particle size distribution?

Quantitative methods for determining particle size distribution involve measuring the frequency or proportion of particles within specific size ranges in a sample. Common quantitative methods include:

  1. Laser diffraction: Laser diffraction techniques analyze the scattering patterns of laser light passing through a sample containing particles, providing information on particle size distribution based on the intensity of scattered light at different angles.
  2. Dynamic light scattering (DLS): DLS measures the fluctuations in scattered light intensity caused by the Brownian motion of particles in a suspension, yielding particle size distribution information based on the autocorrelation function of intensity fluctuations.
  3. Nanoparticle tracking analysis (NTA): NTA systems visualize and track individual nanoparticles in suspension using light microscopy and particle tracking algorithms, providing real-time size distribution and concentration data.
  4. Sedimentation methods: Sedimentation techniques such as analytical ultracentrifugation (AUC) or centrifugal sedimentation measure the sedimentation rate of particles in a liquid medium, yielding information on particle size distribution based on the sedimentation coefficient or size distribution coefficient.
  5. Microscopy image analysis: Microscopic techniques such as optical microscopy or electron microscopy combined with image analysis software quantify the number and size of particles in captured images, providing particle size distribution data based on image processing such as Aura Systems with Particle Vue Software.

These quantitative methods offer precise and reliable approaches to characterizing particle size distribution, enabling researchers to assess the uniformity, stability, and performance of particulate samples in various applications

What are the most common particulate contaminants?

What are the most common particulate contaminants?

Particulate contaminants in pharmaceutical products can arise from various sources and may include foreign particles such as glass shards, metal fragments, fibers, or microbial contaminants. Common particulate contaminants encountered in pharmaceutical manufacturing include visible particles (>50 micrometers), subvisible particles (1-50 micrometers), and microbial particles (e.g., bacteria, fungi). These contaminants can originate from raw materials, packaging components, manufacturing equipment, or environmental sources. Particulate contamination poses risks to product quality, efficacy, and patient safety, necessitating rigorous quality control measures and analytical testing throughout the manufacturing process to detect and mitigate contamination issues.

What is a particle count test in the pharmaceutical industry?

What is a particle count test in the pharmaceutical industry?

Particle count testing in the pharmaceutical industry involves quantifying the number and size distribution of particles present in pharmaceutical formulations or manufacturing processes. This testing is critical for assessing product quality, ensuring compliance with regulatory standards, and identifying potential contamination issues. USP 788 has largely been accepted as the industry standard for particle count testing guidance. Common methods for particle count testing include light obscuration, microscopy particle counting, and dynamic image analysis. These techniques provide quantitative data on the concentration and size distribution of particles, enabling manufacturers to monitor and control particle levels within acceptable limits. The Aura family of instruments can identify, size and count microbial particles easily, accurately and quickly. Particle count testing is particularly important for injectable drug products, where excessive particulate matter can pose risks to patient safety, such as embolism or injection site reactions.

How can we control contamination in the pharmaceutical industry?

How can we control contamination in the pharmaceutical industry?

Controlling contamination requires implementing comprehensive quality control measures and adhering to good manufacturing practices (GMP). Key strategies for contamination control include:

  1. Facility design and maintenance: Designing facilities with controlled environments, proper ventilation, and segregated areas for different manufacturing processes to prevent cross-contamination.
  2. Personnel training and hygiene: Training on proper gowning procedures, hygiene practices, and aseptic techniques to minimize the risk of microbial contamination.
  3. Raw material and equipment control: Procedures for the qualification and validation of raw materials, equipment, and packaging components to ensure their suitability and cleanliness.
  4. Cleaning and sanitation: Establishing robust cleaning and sanitation protocols for equipment, facilities, and production areas to prevent microbial growth and cross-contamination.
  5. Environmental monitoring: Routine monitoring of air, water, and surfaces for microbial contamination to identify and address potential sources of contamination.
  6. Quality control testing: Performing analytical testing and inspection of raw materials, intermediates, and finished products to detect and mitigate contamination issues.
  7. Regulatory compliance: Adhering to regulatory guidelines and standards, such as government regulations, good manufacturing practices (GMP) and pharmacopeial requirements, to ensure product quality and safety.

What are cells made of and what characteristics do all cells have?

What are cells made of and what characteristics do all cells have?

All cells share certain fundamental characteristics, some of these including:

  • Plasma Membrane: Cells are surrounded by a plasma membrane that separates the cell from its environment and regulates the passage of molecules in and out of the cell.
  • Genetic Material: Cells contain genetic material, typically DNA (deoxyribonucleic acid) in the form of chromosomes, which carries the instructions for cell function and heredity.
  • Cytoplasm: The cytoplasm is the gel-like substance inside the cell that contains various organelles, such as mitochondria, endoplasmic reticulum, and ribosomes, involved in cellular processes.
  • Metabolism: Cells carry out metabolic processes to obtain energy and synthesize biomolecules necessary for cell growth, maintenance, and function.
  • Reproduction: Cells have the ability to reproduce and divide to produce new cells through processes such as mitosis or meiosis.

These fundamental characteristics are essential for the survival and function of all cells, regardless of their type or function within an organism.

What is a Polydispersity Index (PDI)?

What is a Polydispersity Index (PDI)?

The polydispersity index (PDI) is a measure of the width of the particle size distribution in a sample. A low PDI indicates a more uniform particle size, which is often desired for stability and performance in pharmaceutical formulations.


Related

Conduct particle size analysis in as little as 5 µL with particle presence and formation information early in discovery and development with Waters Aura particle analyzers.

Learn more about Particle Counting and Identification Solutions.

Learn more about Particle Counting and Identification Solutions.

Plexus intermeshed into form wave
Back To Top Back To Top